Also from this source

You just read:

NeoGenomics is the First Laboratory to Offer Calreticulin (CALR) Mutation Testing for the Diagnosis and Classification of Myeloproliferative Neoplasms

News provided by

NeoGenomics, Inc.

Jan 07, 2014, 07:00 EST